KIRSTYN VEGA: Open Payments
NPI 1184961435 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$758 in 40 payments from 11 companies in 2025. Trend: 2023 $425 · 2024 $511 · 2025 $758
Food & beverage: $645Education: $113
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 17 | $192 |
| GENZYME CORPORATION | 7 | $184 |
| Janssen Biotech, Inc. | 7 | $166 |
| UCB, Inc. | 2 | $71 |
| Regeneron Healthcare Solutions, Inc. | 1 | $33 |
| Incyte Corporation | 1 | $25 |
| Lilly USA, LLC | 1 | $21 |
| ABBVIE INC. | 1 | $20 |
| Verrica Pharmaceuticals Inc. | 1 | $20 |
| Galderma Laboratories, L.P. | 1 | $14 |
Products named: DUPIXENT, TREMFYA, CIBINQO, Bimzelx, EUCRISA, OPZELURA, TALTZ, SKYRIZI.
Industry payments across NC — which companies pay providers there.
